CAN CARDIOVASCULAR DISEASE BE CAUSED BY THYROID PATHOLOGY?

Authors

  • Tatiana Bento Interna de Formação Específica em Medicina Geral e Familiar; USF Vale do Sorraia, Portugal
  • Mariana Santos Miranda Interna de Formação Específica em Medicina Geral e Familiar; USF Vale do Sorraia, Portugal
  • Raquel Landeiro Especialista em MGF; USF Vale do Sorraia, Portugal

DOI:

https://doi.org/10.58043/rphrc.104

Keywords:

cardiovascular disease, thyroid pathology, hypothyroidism, hyperthyroidism

Abstract

Introduction: Thyroid pathology and cardiovascular disease (CVD) are very prevalent in the general population. Some studies demonstrate an association between thyroid dysfunction and CVD. Taking into account that CVD can increase the risk of events and mortality, it’s important to know modifiable risk factors and act on them.

Objective: The aim of this study is to verify whether thyroid pathology is associated with CVD in the adult population.

Material and Methods: Evidence-based review of systematic reviews (SR), meta-analyses (MA) and randomized clinical trials (RCT), in Portuguese and English, published in the last 10 years, in the PubMed database using the MeSH terms “cardiovascular diseases” and “thyroid diseases”. The Strength of Recommendation Taxonomy (SORT) Scale from the American Family Physician was used to assess the level of evidence and recommendation strength.

Results: 99 articles were found of which 73 were excluded after reading the title, 12 after reading the abstract and 4 after reading the full article, being selected 10 for analysis (4 MA, 2 RS e 4 MA+RS). According to Smedegaard et al., subclinical hyperthyroidism can cause atrial fibrillation (AF) and heart failure (HF), Ding and Gong et al. mentioned an association with metabolic syndrome (increased risk of obesity, hypertension, high level of triglycerides and total and low-density cholesterol, low level of high-density lipoprotein), and Srisawat referred association between hyperthyroidism and venous thromboembolism. Huang mentioned that subclinical hypothyroidism is associated with AF, and Collet stated an association with coronary disease regardless the presence of antibodies. Floriani et al. reported than subclinical hypothyroidism with TSH ≥ 10 mlU/L and subclinical hyperthyroidism with TSH < 0,1 MlU/L increase the risk of mortality so should be treated. Kostopoulos et al. mentioned an association between differentiated thyroid carcinoma and a higher risk of developing AF.

Conclusion: Most studies show an association between thyroid pathology and CVD, as AF and other arrhythmias, HF, increased CV risk and mortality. Therefore, some studies refer to the importance of tracking and treating dysfunction, even if it is subclinical. However, this association remains controversial and it’s important to carry out more studies and more robust ones.

Downloads

Download data is not yet available.

References

Freitas, C. et al. Documento de Consenso da Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (SPEDM) e do Grupo de Estudos da Tiroide (GET) sobre Diagnóstico, Tratamento e Seguimento do Hipotiroidismo Primário no Adulto. Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo 14, 167– 179 (2019).

Omidi, N., Khorgami, M., Tajrishi, F. Z., Seyedhoseinpour, A. & Pasbakhsh, P. The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature. Curr Cardiol Rev 16, 103–116 (2020).

Sohn, S. Y., Lee, E., Lee, M. K. & Lee, J. H. The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort 8. Studies. Endocrinology and Metabolism 35, 786–800 (2020).

Huang, M., Yang, S., Ge, G., Zhi, H. & Wang, L. Effects of Thyroid Dysfunction and the Thyroid- Stimulating Hormone Levels on the Risk of 9. Atrial Fibrillation: A Systematic Review and Dose-Response Meta-Analysis from Cohort Studies. Endocrine Practice 28, 822–831 (2022).

Collet, T. H. et al. Thyroid antibody status, subclinical hypothyroidism, and the risk of 10. coronary heart disease: An individual participant

data analysis. Journal of Clinical Endocrinology

and Metabolism 99, 3353–3362 (2014).

Ning, Y. et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. 11. BMC Med 15, (2017).

Floriani, C., Gencer, B., Collet, T. H. & Rodondi, N. Subclinical thyroid dysfunction and 12. cardiovascular diseases: 2016 update. European Heart Journal vol. 39 503–507 Preprint at https:// doi.org/10.1093/eurheartj/ehx050 (2018).

Gong, N., Gao, C., Chen, X., Fang, Y. & Tian, L. Endothelial Function in Patients with Subclinical Hypothyroidism: A Meta-Analysis. Hormone and Metabolic Research vol. 51 691–702 Preprint at https://doi.org/10.1055/a-1018-9564 (2019).

Srisawat, S., Sitasuwan, T. & Ungprasert, P. Increased risk of venous thromboembolism among patients with hyperthyroidism: a systematic review and meta-analysis of cohort studies. Eur J Intern Med 67, 65–69 (2019).

Med, D. et al. Systematic Review Subclinical hyperthyroidism and the risk of Subclinical hyperthyroidism and the risk of developing cardiovascular disease-a developing cardiovascular disease-a systematic review systematic review. J vol. 67 https://ugeskriftet.dk/files/a12190701_ supplementary.pdf (2020).

Ding, X. et al. The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.

Kostopoulos, G. et al. Incident atrial fibrillation in patients with differentiated thyroid cancer: a meta-analysis. Endocr Relat Cancer 28, 325–335 (2021).

Published

2023-10-19

How to Cite

1.
Bento T, Santos Miranda M, Landeiro R. CAN CARDIOVASCULAR DISEASE BE CAUSED BY THYROID PATHOLOGY?. RH [Internet]. 2023 Oct. 19 [cited 2024 Nov. 23];(97):26-30. Available from: https://revistahipertensao.pt/index.php/rh/article/view/104

Issue

Section

Caso Clínico